The refillable eye implants continuously deliver a customised formulation of a drug over a period of several months. Read ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic ...

The eye provides a unique, open, and accessible window for directly imaging small vessels in the retina with non-invasive techniques, such as fundoscopy. In this context, accurate registration of ...

Background/aims To determine whether a combination of baseline and change in spectral domain-optical coherence tomography (SD-OCT)-based biomarkers can predict visual outcomes in eyes with diabetic ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

A common phrase that macular degeneration patients hear is "There's nothing more we can do". But it couldn't be furth ...

The main outcomes were change in mean VA from baseline, number of injections and clinic visits and characteristics affecting VA change and DR grade. Results Data from 12 989 clinic visits was collated ...

Tivan boss Grant Wilson has delivered two key milestones for Australia's first fluorite development by securing backing from two key partners for up to $107 million in new equity. Japan's Sumitomo ...